Order Lab Tests
Physician Portal Login
Moleculera Labs
Menu
  • NEUROPSYCH
    SYMPTOMS
      • About Neuropsychiatric disorder
        Infections and an autoimmune response can cause encephalitis (brain inflammation) which may result in behavioral changes or neuropsychiatric symptoms.
        About Testing
    • Neuropsychiatric Symptoms
      • Symptoms Overview
      • Recognizing Symptoms
      • How Infections Cause
        Neuropsychiatric Symptoms
      • Prescribers:
        Ordering The Panel
      • Patients:
        Ordering The Panel
    • PANS and PANDAS
      • Overview
      • What is PANDAS?
      • PANDAS
        Diagnosis & Treatment
      • What is PANS?
      • PANS
        Diagnosis & Treatment
      • Sydenham’s Chorea
    • ABOUT SYMPTOMS
      • Obsessions & Compulsions
      • Motor & Vocal Tics
      • Attention Deficit
        & Hyperactivity
      • Austim Spectrum
        Disorders
      • Anxiety Disorders
      • Seizures & Convulsions
      • Depression &
        Mood Changes
      • Chronic Fatigue
    • Education: Journal Articles
      • All Peer-Reviewed Articles
      • Cunningham Panel Articles
      • PANS / PANDAS
        Treatment Articles
      • JCAP Articles
    • Videos & Testimonials
      • Patient Stories
      • Clinician Testimonials
      • Moleculera Labs Video
      • Cunningham Panel Video
    • Close
  • Laboratory
    Testing
      • About PANS and PANDAS
        Resource Center
    • The Cunningham Panel
      • Overview of
        The Cunningham Panel™
      • Cunningham Panel™
        Measures
      • Cunningham Panel™
        Sensitivity and Specificity
      • Cunningham Panel™
        Results and Symptoms
    • Clinical Laboratory
      • Laboratory Testing
      • Laboratory Accreditation
    • Ordering Lab Tests
      • Ordering Lab Tests
      • Ordering in US and Canada
      • International Ordering
    • Close
  • Physician
    Resources
      • Physician Resources
        Resource Center
    • Diagnosis and Treatment
      • Diagnosis and Treatment
      • PANDAS Diagnostic Criteria
      • PANS Diagnostic Criteria
    • Ordering CUNNINGHAM PANEL™
      • Ordering Lab Tests
      • International Ordering
      • Letter of Medical Necessity
    • Physician Resources
      • Schedule Consultation
      • Physician FAQ’s
      • Brochures
      • Educational Series
      • Webinars
      • Physician Education
      • PANDAS Physicians Network
    • Physician Library
      • Video Library
      • PANS-PANDAS Treatment
      • JCAP Silver Journal Articles
      • Peer Reviewed Articles
    • Close
  • Parent & Patient
    Resources
      • Parent Resource Center
        Resource Center
        Pay My Bill
        Deposit Payment
    • Cunningham Panel™
      • About Cunningham Panel™
      • Ordering The Panel
      • Ordering Instructions
      • Locating A Lab
      • Testing Costs
    • FAQ Videos
      • Cunningham Panel™ – Results
      • Billing & Insurance
      • Shipping Instructions
    • Patient Stories
      • Grace’s Story
      • 20/20 and Nightline Specials
    • Parent Resources
      • Webinar: How infections can
        trigger neuropsychiatric
        symptoms
      • HIPAA Privacy Practices
      • Parent/Patient FAQ’s
      • Release Of Information
      • Sole Provider Letter
      • Informed Consent
      • Insurance, Billing, Payment
      • Insurance Checklist
      • Moleculera Labs Video
      • Video Library
      • No Surprises Act
    • Close
  • About
    Moleculera
      • About Moleculera Labs
        About Moleculera
    • About Moleculera Labs
      • About Our Company
      • Leadership
      • Board Members and Advisors
      • Moleculera Labs Team
    • Contact Moleculera
      • Moleculera Updates
      • Contact Moleculera
    • Testimonials
      • All Testimonials
      • Testimonial Submission
    • Events
      • All Events
    • News Room
      • News Stories
      • Video & Audio Interviews
      • Interview Request
    • Close
Prescriber Portal Login

Moleculera Labs Leadership

Craig Shimasaki, PhD, MBA

Craig Shimasaki, Ph D, MBA

Co-Founder, President and CEO

View Bio

Madeleine Cunningham, PhD

Madeleine Cunningham, Ph D

Co-Founder, Chief Scientific Officer

View Bio

Fred Hiller

Fred Hiller

Chief Financial Officer

View Bio

About Moleculera
  • About Moleculera Labs
  • Our Company
    • About Our Company
    • Leadership
    • Board Members and Advisors
    • Moleculera Labs Team
  • Events
    • All Events
    • Speaking Events
    • Exhibiting Events
  • Testimonials
    • All Testimonials
    • Testimonial Submission
  • News Room
    • News Stories
    • Video and Audio Interviews
    • Interview Request
  • Moleculera Updates
  • Contact Moleculera Labs

p: (405) 239-5250   |   f: (405) 239-5255   |   755 Research Parkway, Suite 410, Oklahoma City, OK 73104

customerservice@moleculera.com  |  Privacy Policy  |  Terms and Conditions  |  Contact Us  |  No Surprises Act

Moleculera Labs Facebook Moleculera Labs Twitter Moleculera Labs YouTube

© 2023 Moleculera Labs. All rights reserved.

CRAIG SHIMASAKI, Ph D, MBA

Moleculera Labs Co-Founder, President and CEO

mng-Craig-Shimasaki

Dr. Shimasaki is co-founder and CEO of Moleculera Labs, a neuroimmunology precision medicine company focused on diagnosing neurologic, psychiatric, and behavioral disorders triggered by an autoimmune response. The company’s testing panel is based on over 20 years of work from Dr. Madeleine Cunningham’s laboratory at the University of Oklahoma Health Sciences Center. Dr. Shimasaki has been in the biotechnology industry for over 35 years, starting his career at Genentech. As a scientist, businessperson, and serial entrepreneur his work spans all stages of research and development from bench to bedside. His R&D work included epitope mapping for an HIV vaccine, SNP-based genetic breast cancer risk prediction biomarkers, a rapid influenza diagnostic, and therapeutic and biologic products for infectious diseases, neuropsychiatric disorders and noise induced hearing loss. He co-founded several companies and led multiple products through the FDA approval process and is a co-inventor on several patents.

Dr. Shimasaki received his BS in Biochemistry from University of California at Davis, his PhD in Molecular Biology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business. He is an Adjunct Professor and Senior Entrepreneur-in-Residence at the University of Oklahoma, Price School of Business and teaches biotechnology entrepreneurship. His passion is to help translate scientific and medical discoveries into acutely needed products so that more patients can live healthier lives.

MADELEINE CUNNINGHAM, Ph D

Co-Founder, Chief Scientific Officer

MADELEINE CUNNINGHAM, PHD

Dr. Cunningham is Co-founder and Chief Scientific Officer of Moleculera Labs. She is the George Lynn Cross Research Professor and the Presbyterian Health Foundation Presidential Professor and Microbiology and Immunology Director, Immunology Training Program University of Oklahoma Health Sciences Center. Dr. Cunningham’s laboratory has studied molecular mimicry, autoimmunity and infection related to inflammatory heart disease for the past 30 years. She has pioneered the development of human mAbs in understanding the pathogenesis of human diseases. Currently her laboratory is focused on translational studies of human diseases, to improve their diagnosis and treatment and determine how infections play a role in autoimmune diseases of the heart and brain. Dr. Cunningham is the director of an NIAID supported Immunology Training Program at the University of Oklahoma for the past 10 years. She has been the recipient of NHLBI Career Development and MERIT Awards and has been funded by NIH for the past 25 years. She is author of over 100 publications in peer-reviewed journals and speaks internationally on the findings of her research.

Dr. Cunningham’s laboratory studies the role of autoimmunity and infection in the pathogenesis of movement and behavioral disorders associated with streptococci, including Sydenham chorea, the neurologic manifestation of rheumatic fever, and pediatric autoimmune neurologic disorder associated with streptococci (PANDAS). Her laboratory identified antibody mediated neuronal cell signaling as the potential basis for choreic movement disorders. Other related movement and neuropsychiatric disorders such as obsessive compulsive disorder, Tourette’s Syndrome and Tics are under investigation to determine the presence and role of autoantibodies which may signal in the brain for these diseases.

View Dr. Cunningham’s lab at the University of Oklahoma which focuses on the investigation of molecular mimicry, autoimmunity, and infection.

FRED HILLER

Chief Financial Officer

Fred Hiller, CFO

Mr. Hiller is the CFO of Moleculera Labs. He brings over 45 years of strategic financial and operations experience to the company. He began his career as a certified public accountant with Touche Ross & Co. from 1962 to 1968. Between 1969 and 1993, he served in various corporate financial capacities at several multinational companies. Mr. Hiller was the corporate controller of Elgin National Industries Inc. and Columbia Pictures Industries, Inc. and was chief financial officer of Wilkinson Sword, Inc. Mr. Hiller has been a financial consultant to numerous companies since 1994. Mr. Hiller served as Chief Financial Officer for a publicly traded biotechnology company and a genetic-based CLIA laboratory testing for breast cancer risk assessment.

B. Robert Mozayeni, MD

Medical and Clinical Advisor

B. Robert Mozayeni MD

Dr. B. Robert Mozayeni was trained in Internal Medicine and Rheumatology at Yale and at NIH. He has had pre- and post-doctoral Fellowships in Molecular Biophysics and Biochemistry at Yale, and also at NIH where he was a Howard Hughes Research Scholar at LMB/DCBD/NCI and later, Senior Staff Fellow at LMMB/NHLBI/NIH. Editorial board of Infectious Diseases – Surveillance, Prevention and Treatment. Past President of the International Lyme and Associated Diseases Society (ILADS).

He is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently. He is a Fellow of the non-profit Think Lead Innovate Foundation and is a co-founder of the Foundation for the Study of Inflammatory Diseases. He is a Founder of the Foundation for the Study of Inflammatory Diseases to crowd-source medical solutions for complex conditions using existing knowledge, diagnostic methods, and therapies to meet patient needs immediately. He is the Chief Medical Officer of Galaxy Diagnostics, LLC. He is a Board member of the Human-Kind Alliance. Dr. Mozayeni has held admitting privileges (since 1994) on the clinical staff of Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the National Institutes of Health Clinical Center.

Safedin Sajo Beqaj, PhD, HCLD, CC (ABB)

Moleculera Labs, Clinical Laboratory Advisor
Medical Database, Inc., President and CEO

Sajo Baqaj, PhD

Dr. Sajo Beqaj is board certified in molecular pathology and genetics and licensed as a Bioanalyst and High Complexity Laboratory Director. He has been practicing as a laboratory director since 2005.

Dr. Beqaj served as a technical director and was part of the initial management team for several well-known laboratories in the clinical lab industry including PathGroup, Nashville, TN; DCL Medical Laboratories, Indianapolis, IN, and Pathology, Inc, Torrance, CA. He is currently serving as off-side CLIA laboratory director for BioCorp Clinical Laboratory, Whittier, CA and Health360 Labs, Garden Grove, CA.

Dr. Beqaj received his Ph.D. in Pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003 and with Children’s Hospital and Northwestern University from 2003-2005.

Dr. Beqaj has taught in several academic institutions and has published numerous medical textbook chapters and journal articles. He has served as a principal investigator in clinical trials for several well-known pharmaceutical and diagnostic companies such as Roche HPV Athena, Merck HPV vaccine, BD vaginitis panel, Roche (Vantana) CINtec® Histology clinical trials, and has presented various scientific clinical abstracts and presentations.

He is a member of several medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees, and has assisted several laboratories and physicians as a Clinical Laboratory Consultant.

  • NEUROPSYCH SYMPTOMS
    • Neuropsychiatric Symptoms
      • Symptoms Overview
      • Recognizing Symptoms
      • How Infections Cause Neuropsychiatric Symptoms
      • Autoimmunity Testing
    • About Symptoms
      • Obsessions & Compulsions
      • Motor & Vocal Tics
      • Attention Deficit & Hyperactivity
      • Austim Spectrum Disorders
      • Anxiety Disorders
      • Seizures & Convulsions
      • Depression & Mood Changes
      • Chronic Fatigue
    • PANS and PANDAS
      • Overview
      • What Is PANDAS?
      • PANDAS Diagnosis & Treatment
      • What is PANS?
      • PANS Diagnosis & Treatment
      • Sydenham’s Chorea
    • Education: Journal Articles
      • All Peer-Reviewed Articles
      • Cunningham Panel Articles
      • PANS / PANDAS Treatment Articles
      • JCAP Articles
    • Videos & Testimonials
      • Patient Stories
      • Clinician Testimonials
      • Moleculera Labs Video
      • Cunningham Panel Video
  • LABORATORY TESTING
    • Resource Center
    • The Cunningham Panel
      • Overview
      • Cunningham Panel™ Measures
      • Sample Report
    • Clinical Laboratory
      • Laboratory Testing
      • Laboratory Accreditation
    • Ordering Lab Tests
      • Ordering Lab Tests
      • Ordering in US and Canada
      • International Ordering
  • PHYSICIAN RESOURCES
    • Resource Center
    • Diagnosis and Treatment
      • Overview
      • PANDAS Diagnostic Criteria
      • PANS Diagnostic Criteria
    • Ordering Cunningham Panel™
      • Ordering Lab Tests
      • International Ordering
      • Letter of Medical Necessity
    • Physician Resources
      • Schedule Consultation
      • Physician FAQ’s
      • Cunningham Panel™ − Educational Materials
      • Educational Series
      • Physician Education
      • PANDAS Physicians Network
    • Physician Library
      • Video Library
      • PANS-PANDAS Treatment
      • JCAP Silver Journal Articles
      • Peer Reviewed Articles
  • PARENT & PATIENT RESOURCES
    • Resource Center
    • Pay My Bill
    • Deposit Payment
    • Cunningham Panel™
      • About Cunningham Panel™
      • Ordering The Panel
      • Ordering Instructions
      • Locating A Lab
      • Testing Costs
    • FAQ Videos
      • Cunningham Panel™ – Results
      • Billing & Insurance
      • Shipping Instructions
    • Patient Stories
      • Grace’s Story
      • 20/20 and Nightline Specials
    • Parent Resources
      • HIPAA Privacy Practices
      • Parent/Patient FAQ’s
      • Release Of Information
      • Sole Provider Letter
      • Informed Consent
      • Insurance, Billing, Payment
      • Insurance Checklist
      • Moleculera Labs Video
      • Video Library
  • ABOUT MOLECULERA
    • About Moleculera Labs
      • About Our Company
      • Leadership
      • Board Members and Advisors
      • Moleculera Labs Team
    • Contact Moleculera
      • Moleculera Updates
      • Contact Moleculera
    • Testimonials
      • All Testimonials
      • Testimonial Submission
    • Events
      • All Events
    • News Room
      • News Stories
      • Video & Audio Interviews
      • Interview Request
This site uses cookies to improve your experience. By continuing to use our website, you agree to our privacy policy and terms of agreement. Learn More